Items where authors include "Jani, M"

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 7.

Article

Curry, PDK, Chinoy, H, Jani, M et al. (8 more authors) (2023) The impact of COVID-19 on medication adherence in a rheumatoid (BRAGGSS) and psoriatic arthritis (OUTPASS) UK cohort. The Journal of Rheumatology, 50 (7). jrheum.2022-1277. ISSN 0315-162X

Hum, RM, Ho, P, Nair, N et al. (8 more authors) (2023) Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis. Rheumatology, 62 (6). pp. 2090-2097. ISSN 1462-0324

Dagliati, A, Plant, D, Nair, N et al. (10 more authors) (2020) Latent class trajectory modelling of 2‐components‐DAS28 identifies multiple rheumatoid arthritis phenotypes of response to biologic disease modifying anti‐rheumatic drugs. Arthritis & Rheumatology, 72 (10). pp. 1632-1642. ISSN 2326-5191

Smolen, JS, Landewé, R, Bijlsma, J et al. (46 more authors) (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the Rheumatic Diseases, 76 (6). pp. 960-977. ISSN 0003-4967

Jani, M, Dixon, WG, Kersley-Fleet, L et al. (7 more authors) (2017) Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA. RMD Open, 3 (1). e000314. ISSN 2056-5933

Jani, M, Isaacs, JD, Morgan, AW orcid.org/0000-0003-1109-624X et al. (5 more authors) (2017) High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort. Annals of the Rheumatic Diseases, 76 (1). pp. 208-213. ISSN 0003-4967

Jani, M, Isaacs, JD, Morgan, AW orcid.org/0000-0003-1109-624X et al. (5 more authors) (2016) Detection of anti-drug antibodies using a bridging ELISA compared with radioimmunoassay in adalimumab-treated rheumatoid arthritis patients with random drug levels. Rheumatology, 55 (11). pp. 2050-2055. ISSN 1462-0324

This list was generated on Sat Mar 23 23:32:55 2024 GMT.